Search results for "Patient preference"

showing 8 items of 48 documents

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients

2021

Introduction: Lung cancer is the deadliest and most prevalent cancer worldwide. Lung cancer treatments have different characteristics and are associated with a range of benefits and side effects for patients. Such differences may raise uncertainty among drug developers, regulators, payers, and clinicians regarding the value of these treatment effects to patients. The value of conducting patient preference studies (using qualitative and/or quantitative methods) for benefits and side effects of different treatment options has been recognized by healthcare stakeholders, such as drug developers, regulators, health technology assessment bodies, and clinicians. However, evidence-based guidelines …

medicine.medical_specialtyLung NeoplasmsDecision Making03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingCarcinoma Non-Small-Cell LungNominal group techniqueMethodsmedicineHumans030212 general & internal medicineLung cancerQualitative ResearchReimbursementpatient involvementbusiness.industrylcsh:Public aspects of medicinePublic Health Environmental and Occupational HealthHealth technologyCancerPatient Preferencelcsh:RA1-1270medicine.diseaseFocus groupdrug developmentlung cancerDrug developmentnominal group technique030220 oncology & carcinogenesisFamily medicinefocus group discussiondrug decision-makingPublic Healthbusinesspatient preferencesQualitative researchpatient-centered research
researchProduct

Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting

2021

Background: Advanced treatment options for non-small cell lung cancer (NSCLC) consist of immunotherapy, chemotherapy, or a combination of both. Decisions surrounding NSCLC can be considered as preference-sensitive because multiple treatments exist that vary in terms of mode of administration, treatment schedules, and benefit–risk profiles. As part of the IMI PREFER project, we developed a protocol for an online preference survey for NSCLC patients exploring differences in preferences according to patient characteristics (preference heterogeneity). Moreover, this study will evaluate and compare the use of two different preference elicitation methods, the discrete choice experiment (DCE) and …

medicine.medical_specialtyMedicine (General)Health literacyTask (project management)03 medical and health scienceseducational tool0302 clinical medicineQuality of life (healthcare)R5-920SDG 3 - Good Health and Well-beingMethodsmedicineMedical physicsPreference elicitationReimbursementnon-small cell lung cancerhealth locus of controlProtocol (science)030503 health policy & servicesdiscrete choice experimentGeneral MedicinePreferenceLocus of controlquality of life030220 oncology & carcinogenesisMedicineswing weighting0305 other medical sciencePsychologyhealth literacypatient preferenceFrontiers in medicine
researchProduct

Adherence issues related to sublingual immunotherapy as perceived by allergists.

2010

Silvia Scurati1, Franco Frati1, Gianni Passalacqua2, Paola Puccinelli1, Cecile Hilaire1, Cristoforo Incorvaia3, Italian Study Group on SLIT Compliance 1Scientific and Medical Department, Stallergenes, Milan, Italy; 2Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa; 3Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, ItalyObjectives: Sublingual immunotherapy (SLIT) is a viable alternative to subcutaneous immunotherapy to treat allergic rhinitis and asthma, and is widely used in clinical practice in many European countries. The clinical efficacy of SLIT has been established in a number of clinical trials and meta-analyses. However, because SLIT is self-administered…

medicine.medical_specialtyPathologygenetic structuresefficacyAlternative medicineMedicine (miscellaneous)Adherence Cost Efficacy Side effects Sublingual immunotherapySettore MED/10 - Malattie Dell'Apparato Respiratoriosublingual immunotherapyALLERGENcostmedicineSubcutaneous immunotherapySublingual immunotherapyadherenceClinical efficacyIntensive care medicinePharmacology Toxicology and Pharmaceutics (miscellaneous)sublingual immunoterapyOriginal ResearchAsthmaAEROALLERGENSadherence; sublingual immunotherapy; efficacy; cost; side effectsbusiness.industryHealth Policymedicine.diseaseSliteye diseasesClinical trialside effectsPatient Preference and Adherenceadherence; sublingual immunoterapy; efficacy; cost; side effects.immunotherapysense organsAllergistsADHERENCE TO TREATMENTbusinessSocial Sciences (miscellaneous)
researchProduct

Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia

2011

Jorge Mauriño1, Julio Sanjúan2, Josep Maria Haro3, Teresa Díez1, Javier Ballesteros41AstraZeneca Medical Department, Madrid, Spain; 2Department of Psychiatry, University of Valencia, CIBERSAM, Valencia, Spain; 3Parc Sanitari Sant Joan de Deu, CIBERSAM, Sant Boi de Llobregat, Spain; 4Department of Neuroscience-Psychiatry, University of the Basque Country, UPV/EHU, CIBERSAM, Leioa, SpainObjective: The subjective experience of psychotic patients toward treatment is a key factor in medication adherence, quality of life, and clinical outcome. The aim of this study was to assess the subjective well-being in patients with schizophrenia and to examine its relationsh…

medicine.medical_specialtyShort ReportPHARMACOLOGY TOXICOLOGY AND PHARMACEUTICSMedicine (miscellaneous)patient-reported outcomeCorrelationdepressive symptomsSOCIAL SCIENCESQuality of lifeInternal medicineHEALTH POLICY AND SERVICESMedicineSubjective well-beingPsychiatryPharmacology Toxicology and Pharmaceutics (miscellaneous)Depressive symptomsRank correlationMEDICINEbusiness.industryHealth PolicyArea under the curvemedicine.diseaseschizophreniapatient reported outcomesubjective well beingsubjective well-beingPatient Preference and AdherenceSchizophreniaPatient-reported outcomebusinessSocial Sciences (miscellaneous)Patient Preference and Adherence
researchProduct

When to use frovatriptan in migraine? A reply

2011

Dear Sir, We read with interest the comments of Dr. Tfelt-Hansen [1] on the two recently published randomized controlled trials comparing patients’ preference (primary end-point) and efficacy (secondary end-points) of frovatriptan with respect to rizatriptan [2] and almotriptan [3]. In both studies, frovatriptan showed similar preference and short-term efficacy outcomes (pain relief and pain free episodes at 2 h) with respect to the other two triptans. The principal concern of Dr. Tfelt-Hansen was the very early use of frovatriptan in these studies, making their results hardly comparable with those of previous randomized controlled trials [4–6], where patients waited until the headache was …

medicine.medical_specialtybusiness.industryClinical NeurologyGeneral MedicineTriptansPlacebomedicine.diseaseRizatriptanlaw.inventionSumatriptanAnesthesiology and Pain MedicineRandomized controlled trialMigrainelawAlmotriptanInternal medicineMedicineMigraine Frovatriptan Almotriptan Patient preferenceNeurology (clinical)businessPsychiatryFrovatriptanLetter to the Editormedicine.drug
researchProduct

Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice

2018

Bernd Tischer,1 Renato Marino,2 Mariasanta Napolitano3 1Kantar Health, Munich, Germany; 2Haemophilia and Thrombosis Centre, University Hospital of Bari, Apulia, Italy; 3University of Palermo, Reference Regional Center for Thrombosis and Hemostasis Hematology Unit, Palermo, Italy Objectives: To gain insights into the usage of factor VIII (FVIII) products by patients diagnosed with moderate/severe hemophilia A, and to assess the impact and perceived importance of product storage.Methods: In this study, 200 patients diagnosed with moderate or severe hemophilia A across seven countries participated. Data were collected via a 30-minute, face-to-face interview in six countries and via a web-based…

medicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitieshemophilia A recombinant FVIII plasma-derived FVIII storage reconstitution stabilityTreatment Adherence haemophiliaActivities of daily livingMedicine (miscellaneous)030204 cardiovascular system & hematologySevere hemophilia AHaemophiliaHemophilia Astorage03 medical and health sciences0302 clinical medicinePatient satisfactionrecombinant FVIIIplasma-derived FVIIIhemic and lymphatic diseasesMedicine030212 general & internal medicineProduct (category theory)Pharmacology Toxicology and Pharmaceutics (miscellaneous)Original Researchlcsh:R5-920business.industryHealth Policystabilitymedicine.diseasePatient preferenceConjoint analysisProduct choicePatient Preference and AdherenceEmergency medicinereconstitutionbusinesslcsh:Medicine (General)Social Sciences (miscellaneous)Patient Preference and Adherence
researchProduct

Early virologic response with pegylated interferons

2004

Abstract Recently, 12-week evaluation of viral response has been recommended as a means of reducing antiviral treatment morbidity and costs. The development of early stopping rules relies on an important assumption: rules must minimise discontinuation of treatment in patients who might ultimately respond after completion of the full course of therapy. Minimising loss of potential responders is the most important clinical goal in defining an early stopping rule because it provides the most sustained virological responders. This definition of the rule relies on maximising the negative predictive value. Conversely, rules that select patients based on optimising the positive predictive value pr…

medicine.medical_specialtystopping rulesEarly stoppingHepatologyCombination therapybusiness.industryGastroenterologyPredictive valuePatient preferenceSurgeryDiscontinuationearly virological responsePegylated interferonVirologic responsemedicinepegylated interferonIn patientIntensive care medicinebusinessmedicine.drugDigestive and Liver Disease
researchProduct

Appropriateness of surgery performed for abdominal aortic aneurysm at tertiary hospitals in Spain

2021

Background: The aim of this study was to analyze the appropriateness of the type of repair (open or endovascular) performed for abdominal aortic aneurysm (AAA) in five university hospitals in Spain, according to evidence-based recommendations. Methods: A multicenter, retrospective cross-sectional study of patients with AAA who underwent elective open surgical repair (OSR) or endovascular aneurysm repair (EVAR). Data were collected on demographic and clinical variables and type of surgical repair. A pair of vascular surgeons from each participating hospital performed a blinded assessment based on GRADE recommendations. The concordance between the two evaluators and the agreement between thei…

operativemedicine.medical_specialtyConcordancemedicine.medical_treatmentPatient characteristicsEndovascular aneurysm repairTertiary Care CentersBlood Vessel Prosthesis ImplantationSurgical proceduresAbdomenHumansMedicineAgedRetrospective StudiesSurgical repairAortic aneurysmbusiness.industryEndovascular Proceduresmedicine.diseaseUniversity hospitalAneurysmPatient preferenceAbdominal aortic aneurysmSurgeryCross-Sectional StudiesTreatment OutcomeElective Surgical ProceduresSpainCharlson comorbidity indexabdominalCardiology and Cardiovascular MedicinebusinessAortic Aneurysm AbdominalInternational Angiology
researchProduct